Ethnic background as a risk factor for advanced age-related macular degeneration in Israel

Israel Medical Association Journal

Volumn 9, Issue 9, 2007, Pages 656-658

  Abu Asleh, Saleh ^a   Chowers, Itay ^a  

^a HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

Author keywords

Age related macular degeneration; Arabs; Blindness; Ethnic background; Jews

Indexed keywords

AGED; ARAB; ARTICLE; BLINDNESS; CONTROLLED STUDY; DIABETIC RETINOPATHY; ENVIRONMENTAL FACTOR; ETHNIC DIFFERENCE; HEREDITY; HUMAN; ISRAEL; JEW; LOW LEVEL LASER THERAPY; MAJOR CLINICAL STUDY; PHOTODYNAMIC THERAPY; PREVALENCE; RETINA MACULA AGE RELATED DEGENERATION; RETINA NEOVASCULARIZATION; RETROSPECTIVE STUDY; RISK FACTOR;

AGED; ARABS; BLINDNESS; DIABETIC RETINOPATHY; HUMANS; ISRAEL; JEWS; MACULAR DEGENERATION; PHOTOCHEMOTHERAPY; RETROSPECTIVE STUDIES; RISK FACTORS;

EID: 34848895775     PISSN: 15651088     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Evans JR. Risk factors for age-related macular degeneration [Reviewl. Prog Retin Eye Res 2001;20:227-53.
2. Klein R, Peto T, Bird A, Vannewkirk MR. The epidemiology of age-related macular degeneration [Review]. Am J Ophthalmol 2004; 137:486-95.
3. Klein R, Klein BE, Cruickshanks KJ. The prevalence of age-related maculopathy by geographic region and ethnicity [Reviewl. Prog Retin Eye Res 1999;18:371-89.
4. Klein R, Clegg L, Cooper LS, et al. Prevalence of age-related maculopathy in the Atherosclerosis Risk in Communities Study. Arch Ophthalmol 1999;117:1203-10.
5. Klein R, Klein BE, Jensen SC, Mares-Perlman JA, Cruickshanks KJ, Palta M. Age-reiated maculopathy in a multiracial United States population: the National Health and Nutrition Examination Survey III. Ophthalmology 1999;106:1056-65.
6. Klein R, Klein BE, Marino EK, et al. Early age-related maculopathy in the cardiovascular health study. Ophthalmology 2003;110:25-33.
7. Munoz B, Klein R, Rodriguez J, Snyder R, West SK. Prevalence of age-retated macular degeneration in a population-based sample of Hispanic people in Arizona. Proyecto VER. Arch Ophthalmol 2005;123:1575-80.
8. Varma R, Fraser-Bell S, Tan S, Klein R, Azen SP. Prevalence of age-related macular degeneration in Latinos: the Los Angeles Latino eye study. Ophthalmology 2004;111:1288-97.
9. Rahmani B, Tielsch JM, Katz J, et al. The cause-specific prevalence of visual impairment in an urban population. The Baltimore Eye Survey. Ophthalmology 1996;103:1721-6.
10. Sommer A, Tielsch JM, Katz J, et al. Racial differences in the cause-specific prevalence of blindness in east Baltimore. N Engl J Med 1991;325:1412-17.
11. Leske MC, Wu SY, Hennis A, et al. Nine-year incidence of age-related macular degeneration in the Barbados Eye Studies. Ophthalmology 2006;113:29-35.
12. Schachat AP, Hyman L, Leske MC, Connell AM, Wu SY. Features of age-related macular degeneration in a black population. The Barbados Eye Study Group. Arch Ophthalmol 1995;113:728-35.
13. Gregor Z, Joffe L. Senile macular changes in the black African. Br J Ophthalmol 1978;62:547-50.
14. Hoshino M, Mizuno K, Ichikawa H. Aging alterations of retina and choroid of Japanese: light microscopic study of macular region of 176 eyes. Jpn J Ophthalmol 1984;28:89-102.
15. Rennert G, Peterburg Y. Prevalence of selected chronic diseases in Israel. IMAJ 2001;3:404-8.
16. A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E, beta carotene, and zinc for age-related macular degeneration and vision loss: AREDS report no. 8. Arch Ophthalmol 2001;119:1417-36.
17. Baron-Epel O, Haviv-Messika A, Tamir D, Nitzan-Kaluski D, Green M. Multiethnic differences in smoking in Israel: pooled analysis from three national surveys. Eur J Public Health 2004;14:384-9.
18. Jampol LM, Tielsch J. Race, macular degeneration, and the Macular Photocoagulation Study. Arch Ophthalmol 1992;110:1699-700.